We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · November 23, 2020

Introduction and Switching of Biologics and Mood Disorders in Patients With Inflammatory Rheumatic Disease

RMD Open

 

Additional Info

RMD Open
Introduction and Switching of Biologic Agents Are Associated With Antidepressant and Anxiolytic Medication Use: Data on 42 815 Real-World Patients With Inflammatory Rheumatic Disease
RMD Open 2020 Sep 01;6(3)e001303, VK Bournia, MG Tektonidou, D Vassilopoulos, K Laskari, S Panopoulos, K Fragiadaki, K Mathioudakis, A Tsolakidis, P Mitrou, PP Sfikakis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading